SUSIX
Price
$14.63
Change
-$0.06 (-0.41%)
Updated
Aug 31 closing price
Net Assets
334.55M
VITSX
Price
$182.63
Change
-$1.43 (-0.78%)
Updated
Sep 1 closing price
Net Assets
2.29T
Interact to see
Advertisement

SUSIX vs VITSX

SUSIX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
SUSIX vs. VITSX commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUSIX is a StrongBuy and VITSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.29T vs. SUSIX (335M). VITSX pays higher dividends than SUSIX: VITSX (1.03) vs SUSIX (0.46). SUSIX was incepted earlier than VITSX: SUSIX (29 years) vs VITSX (29 years). SUSIX (0.38) is less costly to investors than VITSX (0.03). SUSIX is a more actively managed with annual turnover of: 43.00 vs. VITSX (3.00). VITSX has a lower initial minimum investment than SUSIX: VITSX (5000000) vs SUSIX (10000000). VITSX annual gain was more profitable for investors over the last year : 18.96 vs. SUSIX (9.28). VITSX return over 5 years is better than : 62.04 vs. SUSIX (-15.43).
SUSIXVITSXSUSIX / VITSX
Total Expense Ratio0.380.031,267%
Annual Report Gross Expense Ratio0.380.031,267%
Fund Existence29 years29 years-
Gain YTD10.61712.80483%
Front LoadN/AN/A-
Min. Initial Investment100000005000000200%
Min. Initial Investment IRAN/AN/A-
Net Assets335M2.29T0%
Annual Yield % from dividends0.461.0345%
Returns for 1 year9.2818.9649%
Returns for 3 years40.3868.7959%
Returns for 5 years-15.4362.04-25%
Returns for 10 years21.13250.168%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNWCX102.700.06
+0.06%
American Funds New World 529-C
TBGVX32.64N/A
N/A
Tweedy, Browne International Value Fund
RYCFX54.34N/A
N/A
Rydex Biotechnology C
NQVRX74.82N/A
N/A
Nuveen Multi Cap Value I
HRMDX15.27N/A
N/A
Heartland Mid Cap Value Investor